Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation (Q45456530)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2005

Language	Label	Description	Also known as
English	Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation	scientific article published in July 2005

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

electroporation

1 reference

based on heuristic

inferred from title

author name string

Jianjun Chen

1

1 reference

Europe PubMed Central

14 December 2017

Fang Fang

2

1 reference

Europe PubMed Central

14 December 2017

Xiangzhong Li

3

1 reference

Europe PubMed Central

14 December 2017

Haiyan Chang

4

1 reference

Europe PubMed Central

14 December 2017

Ze Chen

5

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

23

1 reference

Europe PubMed Central

14 December 2017

4322-4328

1 reference

Europe PubMed Central

14 December 2017

34

1 reference

Europe PubMed Central

14 December 2017

describes a project that uses

electroporation

1 reference

based on heuristic

inferred from title

Immunity to influenza in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Influenza at Christ's Hospital: March, 1974.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Plasmid DNA expression systems for the purpose of immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Gene transfer into muscle by electroporation in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Recombinant neuraminidase vaccine protects against lethal influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Evolution of the influenza virus neuraminidase gene during drift of the N2 subtype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Protective cellular immunity against influenza virus induced by plasmid inoculation of newborn mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Enhanced protection against influenza virus of mice immunized as newborns with a mixture of plasmids expressing hemagglutinin and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.035

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.03.035

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45456530&oldid=2076964450"